199 related articles for article (PubMed ID: 6396836)
1. The use of new beta-lactam antibiotics in urinary tract infections.
Kosmidis J
Scand J Infect Dis Suppl; 1984; 42():151-4. PubMed ID: 6396836
[TBL] [Abstract][Full Text] [Related]
2. Use of new beta-lactam antibiotics in intraabdominal surgery.
Kager L; Nord CE
Scand J Infect Dis Suppl; 1984; 42():143-50. PubMed ID: 6335598
[TBL] [Abstract][Full Text] [Related]
3. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
Lode H
Int J Clin Pract Suppl; 2002 Mar; (125):10-17; discussion 37-9. PubMed ID: 12014852
[TBL] [Abstract][Full Text] [Related]
4. [Antibiotic therapy in bacterial infections in gynaecology].
Adam D
Geburtshilfe Frauenheilkd; 1982 Sep; 42(9):662-5. PubMed ID: 6923834
[TBL] [Abstract][Full Text] [Related]
5. Aztreonam versus cefamandole in the treatment of urinary tract infections.
Giamarellou H; Koratzanis G; Kanellakopoulou K; Galanakis N; Papoulias G; el Messidi M; Daikos G
Chemioterapia; 1984 Apr; 3(2):127-31. PubMed ID: 6543431
[TBL] [Abstract][Full Text] [Related]
6. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
Kotra LP; Mobashery S
Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections.
Zhao C; Li J; Hou J; Guo M; Zhang Y; Chen Y
Chin Med J (Engl); 2000 Nov; 113(11):1026-30. PubMed ID: 11776118
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
10. The expanding spectrum of beta-lactam antibiotics.
Allan JD; Eliopoulos GM; Moellering RC
Adv Intern Med; 1986; 31():119-46. PubMed ID: 3511613
[No Abstract] [Full Text] [Related]
11. The use of beta-lactam antibiotics in infections--an overview.
Quintiliani R
Scand J Infect Dis Suppl; 1984; 42():99-109. PubMed ID: 6597565
[TBL] [Abstract][Full Text] [Related]
12. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.
Roberts JA; Paratz J; Paratz E; Krueger WA; Lipman J
Int J Antimicrob Agents; 2007 Jul; 30(1):11-8. PubMed ID: 17442541
[TBL] [Abstract][Full Text] [Related]
13. Antibiotics in urology: new essentials.
Wagenlehner FM; Weidner W; Naber KG
Urol Clin North Am; 2008 Feb; 35(1):69-79; vi. PubMed ID: 18061025
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of antibiotic treatment in relation to treatment time.
Norrby SR
Scand J Infect Dis Suppl; 1990; 74():262-9. PubMed ID: 2097714
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
16. Antibiotherapy and pathogenesis of uncomplicated UTI: difficult relationships.
Moura A; Nicolau A; Hooton T; Azeredo J
J Appl Microbiol; 2009 Jun; 106(6):1779-91. PubMed ID: 19210569
[TBL] [Abstract][Full Text] [Related]
17. [Antibacterial therapy of complicated urinary infections in outpatients].
Rafal'skiĭ VV; Strachunskiĭ LS; Kogan MI; Petrov SB; Grinev AV; Shevelev AN
Urologiia; 2004; (5):25-31. PubMed ID: 15560157
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of bacterial beta-lactamase production in the treatment of urinary tract infections with oral beta-lactam-antibiotics].
Naber K; Ahrens T; Zimmermann W; Puppel H; Schultheis H; Maly V
Urologe A; 1982 Jul; 21(4):225-8. PubMed ID: 6982557
[TBL] [Abstract][Full Text] [Related]
19. [Microbiol landscape and production of beta-lactamases with extended spectrum activity in patients with urinary tract infection].
Zhevlakova IuA; Zakharova GV; Khokhlova OI; Ust'iantseva IM
Klin Med (Mosk); 2009; 87(3):56-9. PubMed ID: 19469259
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
